NVZMY News and Press, Novozymes A/S ADR From 01/25/24

Koss Corporation (KOSS) is expected to report for Q2 2024 Waterstone Financial Inc. (WSBF) is expected to report for Q4 2023 Silver Bull Resources Inc (SVBL) is expected to report for quarter end 2023-10-31 Xcel Energy Inc. (XEL) is expected to report $0.85 for Q4 2023 Sodexo ADR ...

2023-12-21 10:27:09 ET Summary Novozymes and Chr. Hansen are close to completing their merger, creating a global bio-solutions leader with strong competitive moats. The combined company is expected to deliver higher revenue growth and increased profitability through cost and reven...

2023-12-05 22:50:05 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-11-14 12:31:15 ET More on Markets Oppenheimer favors tech amid upbeat prediction for S&P 500 Cathie Wood's ARK Invest launches crypto ETFs in partnership with 21Shares $90 per barrel oil prices are very possible - TD Securities Bespoke Investment: Se...

2023-11-07 17:07:59 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-10-26 18:20:09 ET Novozymes A/S (NVZMF) Q3 2023 Results Conference Call October 26, 2023 03:00 AM ET Company Participants Tobias Cornelius Björklund - Head, Investor Relations Ester Baiget - Chief Executive Officer Lars Green - Chief Financial Officer ...

Not Just Yogurt Anymore PR Newswire Launching October 30 - New super-stable probiotic lets functional food manufacturers go beyond dairy FRANKLINTON, N.C. , Oct. 26, 2023 /PRNewswire/ -- Novozymes is excited to launch ProSilience™ HU58, a probi...

Novozymes AS ADR (NVZMY) is expected to report $0.42 for Q3 2023

2023-10-19 11:17:18 ET Novozymes A/S ( OTCPK:NVZMY ) had declared $0.384/share dividend. Payable Nov. 1; for shareholders of record Oct. 23; ex-div Oct. 20. See NVZMY Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Novozymes ...

2023-10-10 21:54:11 ET Summary Novozymes' stock is declining for almost two years and has lost almost 50% of its previous value. The company reported mediocre half-year results for fiscal 2023. But Novozymes has a wide economic moat around its business, making the company a go...